Zymergen Inc.
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. The company primarily serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc. On October 3, 2023, Zymergen Inc along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Market Cap
$253.6M
Volume
1.3M
Cash and Equivalents
$153.4M
EBITDA
-$248.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$186.7M
Profit Margin
1507.33%
52 Week High
$12.42
52 Week Low
$1.10
Dividend
N/A
Price / Book Value
1.50
Price / Earnings
-0.73
Price / Tangible Book Value
1.56
Enterprise Value
$284.2M
Enterprise Value / EBITDA
-1.37
Operating Income
-$270.1M
Return on Equity
106.07%
Return on Assets
-32.77
Cash and Short Term Investments
$153.4M
Debt
$184.0M
Equity
$169.6M
Revenue
$12.4M
Unlevered FCF
-$156.3M
Sector
Chemicals
Category
N/A
Hedge Funds that own this stock
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick PremiumCompany Stock Pitches
No stock pitches match your current filters.
Try adjusting your filters or clearing them and trying again.